Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide
Clinical trial NCT01300793 · TERMINATED
Trial details
- NCT number
- NCT01300793
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2011-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.